News

ORYZON announces successful pre-IND meeting with FDA for the clinical development of vafidemstat in Borderline Personality Disorder

15/03/2021

Oryzon will consequently proceed to file an IND application  PORTICO will be developed in…

BIOLAN has launched its rapid serological test for the detection of antibodies against COVID-19 with a guaranteed industrial production capacity

11/03/2021

The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will…

ORYZON presents vafidemstat 12-month clinical data from its Phase IIa clinical trials ETHERAL and REIMAGINE-AD in Alzheimer’s at the virtual AD/PD-2021 conference

09/03/2021

Drug Developers Can Measure ADCC in Biologically Relevant Systems with New Promega Bioluminescent Primary Cell Bioassay

03/03/2021

Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable…

Partners - Promega

SIEMENS HEALTHINEERS Y IUL SA, una nueva alianza para combatir la COVID-19

23/02/2021

The IUL’s reader, so-called iPeak®, capture, and process the image of the test guaranteeing the…

ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Acute Myeloid Leukemia

11/02/2021

The compound is currently in Phase II Now has orphan designation in both U.S. and EU

Natac have just opened a process of international recruitment and selection of new professionals

10/02/2021

Natac is looking for sales representatives

ZYMVOL and AMINOVERSE team up to develop custom-made alcohol dehydrogenases

12/01/2021

Antibiotic resistance

Primarily used in the Flavours & Fragrances (F&F) and Fine Chemicals industries, alcohol…

Partners - Zymvol Biomodeling

ORYZON to present a corporate update and to hold multiple virtual corporate activities in January-2021

04/01/2021

The company will present recent clinical developments at the H.C. Wainwright Bioconnect, will…